Related Experiment Video
Updated: Feb 14, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Diepoxybutane-induced apoptosis is mediated through the ERK1/2 pathway
E Eluka-Okoludoh1,2, A J Ewunkem2, S Thorpe1
11 Department of Biology, North Carolina A&T State University, Greensboro, NC, USA.
Abstract:
Diepoxybutane (DEB) is the most potent active metabolite of butadiene, a regulated air pollutant. We previously reported the occurrence of DEB-induced, p53-dependent, mitochondrial-mediated apoptosis in human lymphoblasts. The present study investigated the role of the extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) pathway in DEB-induced apoptotic signaling in exposed human lymphoblasts. Activated ERK1/2 and mitogen-activated protein (MAP) kinase/ERK1/2 kinase (MEK) levels were significantly upregulated in DEB-exposed human lymphoblasts. The MEK inhibitor PD98059 and ERK1/2 siRNA significantly inhibited apoptosis, ERK1/2 activation, as well as p53 and phospho-p53 (serine-15) levels in human lymphoblasts undergoing DEB-induced apoptosis. Collectively, these results demonstrate that DEB induces apoptotic signaling through the MEK-ERK1/2-p53 pathway in human lymphoblasts. This is the first report implicating the activation of the ERK1/2 pathway and its subsequent role in mediating DEB-induced apoptotic signaling in human lymphoblasts. These findings contribute towards the understanding of DEB toxicity, as well as the signaling pathways mediating DEB-induced apoptosis in human lymphoblasts.
Insights
Diepoxybutane (DEB), a butadiene metabolite, triggers apoptosis in human cells via the MEK-ERK1/2-p53 pathway. Inhibiting this pathway reduces DEB-induced cell death, offering insights into its toxicity.
Area of Science:
- Toxicology
- Cell Biology
- Molecular Biology
Background:
- Diepoxybutane (DEB) is a potent metabolite of butadiene, a regulated air pollutant.
- Previous research established DEB-induced, p53-dependent, mitochondrial-mediated apoptosis in human lymphoblasts.
Purpose of the Study:
- To investigate the role of the extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) pathway in DEB-induced apoptotic signaling.
- To elucidate the specific signaling cascade involved in DEB toxicity.
Main Methods:
- Human lymphoblasts were exposed to DEB.
- Levels of activated ERK1/2 and mitogen-activated protein (MAP) kinase/ERK1/2 kinase (MEK) were measured.
- The MEK inhibitor PD98059 and ERK1/2 siRNA were used to block the pathway.
- Apoptosis, ERK1/2 activation, and p53/phospho-p53 levels were assessed.
Main Results:
- DEB exposure significantly upregulated ERK1/2 and MEK levels in human lymphoblasts.
- Inhibition of MEK or ERK1/2 significantly reduced DEB-induced apoptosis.
- Blocking the MEK-ERK1/2 pathway also decreased p53 and phospho-p53 levels.
Conclusions:
- DEB induces apoptosis in human lymphoblasts through the MEK-ERK1/2-p53 signaling pathway.
- This study is the first to implicate ERK1/2 pathway activation in mediating DEB-induced apoptosis.
- Findings enhance understanding of DEB toxicity mechanisms and apoptotic signaling in human lymphoblasts.
More Related Videos
Related Concept Videos
Apoptosis
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Receptor-mediated Endocytosis
Other Glycolytic Pathways
Respiration Pathways

